A meeting was held at the office of the Investment Council Secretariat with the Kyrgyz Pharmaceutical Manufacturers Association and the Pharmaceutical and Medical Activities Committee under the Chamber of Commerce and Industry of the Kyrgyz Republic. The discussion focused on the development of the pharmaceutical industry in the country.

Representatives from the association and the committee expressed concerns about the reintroduction of VAT on pharmaceuticals, which had previously been abolished but is now being reinstated according to recent changes. They also emphasized the need for all manufacturers to comply with the international GMP (Good Manufacturing Practice) standard by the end of 2025. Failure to meet this standard could leave only two domestic producers in the market, potentially leading to serious supply issues for pharmaceuticals.

It was also noted that there are interested foreign investors from countries such as China and Japan who are willing to invest in the country's pharmaceutical sector. However, they have expressed concerns about the lack of necessary support from the government, including the provision of electricity, land plots, roads, and water supply.

The Investment Council Secretariat expressed its readiness to support the pharmaceutical industry and assist in resolving the identified issues to promote domestic pharmaceutical production and ensure the population of the Kyrgyz Republic has access to high-quality and affordable medicines.